Quest Diagnostics Prices $500 M 5.00% Senior Notes Due 2036
Quest Diagnostics has priced a $500 million offering of 5.000% senior notes due 2036, with closing scheduled for May 6, 2026 under its shelf registration. The company intends to use net proceeds for general corporate purposes, including repayment of its $500 million 3.45% notes maturing June 1, 2026.
1. Senior Notes Offering
Quest Diagnostics announced the pricing of a $500 million aggregate principal amount of 5.000% senior notes due 2036 under its existing shelf registration. The transaction is expected to close on May 6, 2026, subject to customary closing conditions.
2. Use of Proceeds
The company expects to deploy net offering proceeds for general corporate purposes, which may include repaying its outstanding $500 million 3.45% senior notes maturing on June 1, 2026. This strategic move aligns debt maturities and manages upcoming refinancing needs.
3. Debt Profile and Maturity Extension
By issuing longer-dated 5.000% notes, Quest Diagnostics extends its debt maturity profile by a decade, shifting from a near-term June 2026 payoff to obligations stretching to 2036. The new coupon rate reflects current market conditions and locks in funding costs for an extended period.